8-K
filed April 3, 2025, 7:59 PM ET
ticker SLE
CIK 0001621672
other material
confidence medium
sentiment negative
materiality 0.70
Super League appoints new CEO, reports disappointing Q4/FY2024 results
Super League Enterprise, Inc.
- Aims to achieve EBITDA positive by Q4 2025; realigning cost structure and focusing on higher-margin programs.
- Ann Hand becomes Executive Chair; Matt Edelman promoted to CEO, effective April 1, 2025.
- Director Clark Callendar resigns; Bant Breen, founder of Qnary, appointed as independent director.
- Exclusivity period with Infinite Reality expired; pursuing strategic alternatives with companies near breakeven.
- New CEO Edelman receives $385k salary and 1M share option; Hand $425k salary and 700k option; Haynes $325k and 350k option.
Machine-readable event card
- schema_version
- secwatch.filing_event.v1
- accession
- 0001437749-25-010917
- form_type
- 8-K
- ticker
- SLE
- cik
- 0001621672
- company_name
- Super League Enterprise, Inc.
- filed_at
- 2025-04-03T23:59:59+00:00
- discovered_at
- 2026-05-14T18:02:49.083241+00:00
- generated_at
- 2026-05-23T22:37:47.513634+00:00
- sec_items
- ["2.02", "5.02", "7.01", "9.01"]
- event_type
- other_material
- sentiment
- negative
- materiality_score
- 0.7
- calibrated_materiality_score
- 0.7
- confidence
- medium
- secwatch_canonical_url
- https://secwatch.observer/filing/0001437749-25-010917
- json_url
- https://secwatch.observer/filing/0001437749-25-010917.json
- markdown_url
- https://secwatch.observer/filing/0001437749-25-010917.md
- text_url
- https://secwatch.observer/filing/0001437749-25-010917.txt
- edgar_index_url
- https://www.sec.gov/Archives/edgar/data/1621672/000143774925010917/0001437749-25-010917-index.htm
- edgar_primary_document_url
- https://www.sec.gov/Archives/edgar/data/1621672/000143774925010917/slgg20250403_8k.htm
- generated_by_model
- deepseek-v4-flash:cloud@v2
- review_status
- machine_generated
- human_reviewed
- false
- corrected
- false
- correction_note
- null
- correction_timestamp
- null
- superseded_by
- null
Comparable filings
DGAC
Disciplined Growth Acquisition Corp. closes $150M IPO on NYSE
DISCIPLINED GROWTH ACQUISITION Corp
June 1, 2026, 4:15 PM ET
other_material
Items 1.01, 3.02, 5.02, 5.03, 8.01, 9.01
same fact type: executive_change
same SEC item: 5.02, 9.01
same event type: other_material
similar materiality
This filing
Matthew Edelman was appointed as Chief Executive Officer (“ CEO ”) of the Company, effective April 1, 2025
Comparable filing
John W. Heilshorn, Aaron Spool, Michael Faber, John Ziegelman and Jay Gettenberg (collectively, the “Directors”) were appointed to the board of directors of the Company (the “Board”).
Filing page
SEC filing
ELOX
Eloxx Pharma: 1-for-11 reverse stock split effective May 29; appoints two independent directors
Eloxx Pharmaceuticals, Inc.
June 1, 2026, 7:00 AM ET
other_material
Items 3.02, 3.03, 5.03, 5.02, 9.01
same fact type: executive_change
same SEC item: 5.02, 9.01
same event type: other_material
similar materiality
This filing
Matthew Edelman was appointed as Chief Executive Officer (“ CEO ”) of the Company, effective April 1, 2025
Comparable filing
the Board of Directors (the “Board”) of Eloxx Pharmaceuticals, Inc. (the “Company”) appointed Stephen W. Webster and Nina Kjellson to fill vacancies on the Board
Filing page
SEC filing
FDXF
FedEx Freight completes spin-off from FedEx; $600M drawn, new board and executives appointed
FedEx Freight Holding Company, Inc.
June 1, 2026, 6:46 AM ET
other_material
Items 1.01, 2.03, 3.03, 5.03, 5.01, 5.02, 5.05, 8.01, 9.01
same fact type: executive_change
same SEC item: 5.02, 9.01
same event type: other_material
similar materiality
This filing
Matthew Edelman was appointed as Chief Executive Officer (“ CEO ”) of the Company, effective April 1, 2025
Comparable filing
each of John A. Smith, R. Brad Martin, Jeffrey A. Davis, Donald E. Frieson, Stephen E. Gorman, Robert A. King, Cindy J. Miller, Amy J. Salcido, and Samantha M. Smith was appointed to the Board
Filing page
SEC filing
FXAC
FortuneX Acquisition closes IPO of 8.625M units at $10/unit, raising $86.25M gross
FortuneX Acquisition Corp
May 29, 2026, 5:32 PM ET
other_material
Items 1.01, 3.02, 5.02, 5.03, 9.01
same fact type: executive_change
same SEC item: 5.02, 9.01
same event type: other_material
similar materiality
This filing
Matthew Edelman was appointed as Chief Executive Officer (“ CEO ”) of the Company, effective April 1, 2025
Comparable filing
Effective May 19, 2026, in connection with the effectiveness of the Company’s Registration Statement, Becky Fallon, Sean Michael Deegan, and Robert Labbe became members of the board of directors (the “Board”) of the Company.
Filing page
SEC filing
CRMT
America's Car-Mart forms special committee for strategic alternatives; appoints new independent director
AMERICAS CARMART INC
May 29, 2026, 5:30 PM ET
other_material
Items 1.01, 5.02, 8.01, 9.01
same fact type: executive_change
same SEC item: 5.02, 9.01
same event type: other_material
similar materiality
This filing
Matthew Edelman was appointed as Chief Executive Officer (“ CEO ”) of the Company, effective April 1, 2025
Comparable filing
On May 22, 2026, the Board increased the size of the Board from nine members to ten members and appointed Adam Paul as an independent director, effective immediately.
Filing page
SEC filing
MVST
Microvast CEO converts $25M loan to equity; CAO Eric Garcia departs
Microvast Holdings, Inc.
May 28, 2026, 5:26 PM ET
other_material
Items 5.02, 8.01, 9.01
same fact type: executive_change
same SEC item: 5.02, 9.01
same event type: other_material
similar materiality
This filing
Matthew Edelman was appointed as Chief Executive Officer (“ CEO ”) of the Company, effective April 1, 2025
Comparable filing
On May 27, 2026, Eric N. Garcia ceased to be employed as Chief Accounting Officer of Microvast Holdings, Inc. (the “Company”).
Filing page
SEC filing
LIXT
Lixte Biotechnology pivots to AI energy infrastructure; appoints Denham Capital founder to board
LIXTE BIOTECHNOLOGY HOLDINGS, INC.
June 1, 2026, 8:55 AM ET
other_material
Items 5.02, 7.01, 9.01
same fact type: executive_change
same SEC item: 5.02, 7.01, 9.01
same event type: other_material
This filing
Matthew Edelman was appointed as Chief Executive Officer (“ CEO ”) of the Company, effective April 1, 2025
Comparable filing
On May 29, 2026, the Board of Directors (the “Board”) of Lixte Biotechnology Holdings, Inc., (the “Company”), appointed Stuart D. Porter to serve as a member of the Board, effective May 29, 2026 with a term expiring at the Company’s 2026 Annual Meeting of Stockholders.
Filing page
SEC filing
ENS
EnerSys realigns to three segments, names presidents for NIS, IMS, PPS
EnerSys
May 28, 2026, 4:15 PM ET
other_material
Items 5.02, 7.01, 9.01
same fact type: executive_change
same SEC item: 5.02, 7.01, 9.01
same event type: other_material
This filing
Matthew Edelman was appointed as Chief Executive Officer (“ CEO ”) of the Company, effective April 1, 2025
Comparable filing
As a result of the Company's Segment Realignment there will be a change in executive titles as follows: • Keith D. Fisher – President, Network & Infrastructure Solutions • Chad C. Uplinger – President, Industrial Mobility Solutions • Mark E. Matthews – Chief Technology Officer and President, Precision Power Solutions
Filing page
SEC filing
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.